CLEC9A and breast carcinoma: In the Her2 transgenic mice bearing E0771‐Her2 breast cancers, we observed significant tumour growth inhibition in mice receiving both adoptively transferred CAROT cells (CAROTI+CAROTII) and injections of OVA‐Clec9A‐TNE (the treatment scheme is described in Figure 4a).